COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas
Xiao-cui Nie(China Medical University), Hua‐chuan Zheng(Jinzhou Medical University), Yanan Xing(First Hospital of China Medical University), Yunpeng Liu(Shenyang Institute of Automation), Yasuo Takano(Nihon University), Wan Zhu(Stanford University), Miao Yu(University of Chicago), Xiaoyan Xu(Shenyang Medical College), Jianping Wang(Shandong University)
Cited by 45
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
The molecular mechanisms of chemoresistance in cancers
|Oncotarget|2017|599
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
|Clinical Cancer Research|2018|551
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538